Go offline with the Player FM app!
Antiarrhythmic Drugs
Manage episode 345413927 series 3320136
This week, Rob and Zach will be talking about Antiarrhythmic Drugs
We will be discussing the following topics within this episode on Antiarrhythmic Drugs!
- Defining an Arrhythmia
- Pathophysiology of an Arrhythmia:
- Abnormal Automaticity
- Increased Triggered Activity
- Re-Entrant Circuits
- Antiarrhythmic Drug Categories:
- Class I: Sodium Channel Blockers (Type Ia, Ib, Ic)
- Class II: Beta Blockers
- Class III: Potassium Channel Blockers
- Class IV: Calcium Channel Blockers
- Class V: Miscellaneous
- Adenosine
- Magnesium
- Digoxin
To follow along with Notes & Illustrations for our podcasts please become a member on our website! https:// www.ninjanerd.org/podcast/antiarrhythmic-drugs
Follow us on:
Chapters
1. Antiarrhythmic Drugs (00:00:00)
2. [Ad] The C-Section Experience (00:22:08)
3. (Cont.) Antiarrhythmic Drugs (00:22:47)
80 episodes
Manage episode 345413927 series 3320136
This week, Rob and Zach will be talking about Antiarrhythmic Drugs
We will be discussing the following topics within this episode on Antiarrhythmic Drugs!
- Defining an Arrhythmia
- Pathophysiology of an Arrhythmia:
- Abnormal Automaticity
- Increased Triggered Activity
- Re-Entrant Circuits
- Antiarrhythmic Drug Categories:
- Class I: Sodium Channel Blockers (Type Ia, Ib, Ic)
- Class II: Beta Blockers
- Class III: Potassium Channel Blockers
- Class IV: Calcium Channel Blockers
- Class V: Miscellaneous
- Adenosine
- Magnesium
- Digoxin
To follow along with Notes & Illustrations for our podcasts please become a member on our website! https:// www.ninjanerd.org/podcast/antiarrhythmic-drugs
Follow us on:
Chapters
1. Antiarrhythmic Drugs (00:00:00)
2. [Ad] The C-Section Experience (00:22:08)
3. (Cont.) Antiarrhythmic Drugs (00:22:47)
80 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.